Target Binding Site Detail
| Target General Information | Top | ||||
|---|---|---|---|---|---|
| Target ID | T21678 | Target Info | |||
| Target Name | Alpha-galactosidase A (GLA) | ||||
| Synonyms | Melibiase; INN=Agalsidase; Alpha-D-galactoside galactohydrolase; Alpha-D-galactosidase A | ||||
| Target Type | Successful Target | ||||
| Gene Name | GLA | ||||
| Biochemical Class | Glycosylase | ||||
| UniProt ID | |||||
| Ligand General Information | Top | ||||
|---|---|---|---|---|---|
| Ligand Name | beta-D-galactose | Ligand Info | |||
| Canonical SMILES | C(C1C(C(C(C(O1)O)O)O)O)O | ||||
| InChI | 1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3+,4+,5-,6-/m1/s1 | ||||
| InChIKey | WQZGKKKJIJFFOK-FPRJBGLDSA-N | ||||
| PubChem Compound ID | 439353 | ||||
| Drug Binding Sites of Target | Top | |||||
|---|---|---|---|---|---|---|
| PDB ID: 3S5Z Pharmacological Chaperoning in Human alpha-Galactosidase | ||||||
| Method | X-ray diffraction | Resolution | 2.00 Å | Mutation | No | [1] |
| PDB Sequence |
LDNGLARTPT
41 MGWLHWERFM51 CNLDCQEEPD61 SCISEKLFME71 MAELMVSEGW81 KDAGYEYLCI 91 DDCWMAPQRD101 SEGRLQADPQ111 RFPHGIRQLA121 NYVHSKGLKL131 GIYADVGNKT 141 CAGFPGSFGY151 YDIDAQTFAD161 WGVDLLKFDG171 CYCDSLENLA181 DGYKHMSLAL 191 NRTGRSIVYS201 CEWPLYMWPF211 QKPNYTEIRQ221 YCNHWRNFAD231 IDDSWKSIKS 241 ILDWTSFNQE251 RIVDVAGPGG261 WNDPDMLVIG271 NFGLSWNQQV281 TQMALWAIMA 291 APLFMSNDLR301 HISPQAKALL311 QDKDVIAINQ321 DPLGKQGYQL331 RQGDNFEVWE 341 RPLSGLAWAV351 AMINRQEIGG361 PRSYTIAVAS371 LGKGVACNPA381 CFITQLLPVK 391 RKLGFYEWTS401 RLRSHINPTG411 TVLLQLENTM421
|
|||||
|
|
||||||
| PDB ID: 1R47 Structure of human alpha-galactosidase | ||||||
| Method | X-ray diffraction | Resolution | 3.45 Å | Mutation | No | [2] |
| PDB Sequence |
LDNGLARTPT
41 MGWLHWERFM51 CNLDCQEEPD61 SCISEKLFME71 MAELMVSEGW81 KDAGYEYLCI 91 DDCWMAPQRD101 SEGRLQADPQ111 RFPHGIRQLA121 NYVHSKGLKL131 GIYADVGNKT 141 CAGFPGSFGY151 YDIDAQTFAD161 WGVDLLKFDG171 CYCDSLENLA181 DGYKHMSLAL 191 NRTGRSIVYS201 CEWPLYMWPF211 QKPNYTEIRQ221 YCNHWRNFAD231 IDDSWKSIKS 241 ILDWTSFNQE251 RIVDVAGPGG261 WNDPDMLVIG271 NFGLSWNQQV281 TQMALWAIMA 291 APLFMSNDLR301 HISPQAKALL311 QDKDVIAINQ321 DPLGKQGYQL331 RQGDNFEVWE 341 RPLSGLAWAV351 AMINRQEIGG361 PRSYTIAVAS371 LGKGVACNPA381 CFITQLLPVK 391 RKLGFYEWTS401 RLRSHINPTG411 TVLLQLENTM421
|
|||||
|
|
||||||
| References | Top | ||||
|---|---|---|---|---|---|
| REF 1 | The molecular basis of pharmacological chaperoning in human Alpha-galactosidase. Chem Biol. 2011 Dec 23;18(12):1521-6. | ||||
| REF 2 | The molecular defect leading to Fabry disease: structure of human alpha-galactosidase. J Mol Biol. 2004 Mar 19;337(2):319-35. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.